NCT01182922

Information About a Doctor or a Possibility of Choosing Doctor's Gender and Attendance to Screening Colonoscopy

Is the Information About a Doctor or Possibility of Choosing Doctor's Gender Associated With Attendance to Screening Colonoscopy: Randomized Study With Three Types of Invitations.

• Status: Completed
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 5,100 (actual)
• Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology · Academic / Other
• Sex: All
• Age: 55 Years – 64 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to investigate whether the information about a doctor or possibility to choose doctor's gender included in invitation letter is associated with attendance rate to screening colonoscopy.

Detailed description

Study is performed as a part of NordICC (Clinical trials NCT 00883792) trial, which is intended to investigate the effect of screening colonoscopy on colorectal cancer incidence and mortality. NordICC trial is a multicenter, randomized study conducted in Norway, Sweden, Netherlands and Poland. This study is designed to assess two factors potentially influencing patients attendance. These two factors are: identification of particular doctor performing examination and the possibility of choosing doctor's gender.

Conditions

• Colorectal Cancer
• Screening

Interventions

Type	Name	Description
BEHAVIORAL	Invitation letter	Invitation letter sent 6 weeks prior to prespecified screening colonoscopy appointment date and followed by reminder letter within 3 weeks if no response is received.

Timeline

• Start date: 2010-08-01
• Primary completion: 2011-03-01
• Completion: 2011-08-01
• First posted: 2010-08-17
• Last updated: 2011-11-18

Locations

1 site across 1 country: Poland